INS and type 1 diabetes mellitus: Alternatively, these HbA1c trends could be influenced by the so-called honeymoon phase of T1D, where patients experience a temporary period of remission with lower insulin needs and stable HbA1c levels, typically beginning about 3 months after the onset of insulin therapy and lasting several months (54).